|
Originally published In Press as doi:10.1074/jbc.M211716200 on January 29, 2003
J. Biol. Chem., Vol. 278, Issue 16, 14059-14065, April 18, 2003
Negative Regulation of T Cell Activation by Placental
Protein 14 Is Mediated by the Tyrosine Phosphatase Receptor
CD45*
Jacob
Rachmilewitz §,
Zipora
Borovsky ,
Gregory J.
Riely¶,
Robin
Miller¶, and
Mark L.
Tykocinski¶
From the Goldyne Savad Institute of Gene Therapy,
Hadassah University Hospital, Jerusalem 91120, Israel, the
¶ Department of Pathology, Case Western Reserve University,
Cleveland, Ohio 44106, and the Department of Pathology and
Laboratory Medicine, University of Pennsylvania,
Philadelphia, Pennsylvania 19104
CD45 is the major protein tyrosine phosphatase
receptor on T cell surfaces that functions as both a positive and a
negative regulator of T cell receptor (TCR) signaling. Although CD45 is required for the activation of TCR-associated Src
family kinases, it also dephosphorylates phosphoproteins
involved in the TCR-signaling cascade. This study links CD45 to the
inhibitory activity of placental protein 14 (PP14), a major soluble
protein of pregnancy that is now known to be a direct modulator of T
cells and to function by desensitizing TCR signaling. PP14 and CD45
co-capped with each other, pointing to a physical linkage between the
two. Interestingly, however, the binding of PP14 to T cell
surfaces was not restricted to CD45 alone, with evidence showing that
PP14 binds to other surface molecules in a
carbohydrate-dependent fashion. Notwithstanding the broader
molecular binding potential of PP14, its interaction with CD45 appeared
to have special functional significance. Using transfected derivatives
of the HPB.ALL mutant T cell line that differ in CD45 expression, we
established that the inhibitory effects of PP14 are dependent upon the
expression of intact CD45 on T cell surfaces. Based upon these
findings, we propose a new immunoregulatory model for PP14, wherein one
of its surface molecular targets, CD45, mediates its T cell inhibitory
activity, accounting for the intriguing capacity of PP14 to elevate TCR
activation thresholds and thereby down-regulate T cell activation.
*
This study was supported by National Institutes of Health
Grant R01 AI-38960 and the Greensboro Community Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Goldyne Savad Inst. of
Gene Therapy, Hadassah University Hospital, P.O.B. 12000, Jerusalem
91120, Israel. Tel.: 972-2-677-7848; Fax: 972-2-643-0982; E-mail:
rjacob@hadassah.org.il.
Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. K.W. Lam, P. C.N. Chiu, M.-K. Chung, C.-L. Lee, K.-F. Lee, R. Koistinen, H. Koistinen, M. Seppala, P.-C. Ho, and W. S.B. Yeung
Glycodelin-A as a modulator of trophoblast invasion
Hum. Reprod.,
June 11, 2009;
(2009)
dep205v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-L. Lee, P.-C. Pang, W. S. B. Yeung, B. Tissot, M. Panico, T. T. H. Lao, I. K. Chu, K.-F. Lee, M.-K. Chung, K. K. W. Lam, et al.
Effects of Differential Glycosylation of Glycodelins on Lymphocyte Survival
J. Biol. Chem.,
May 29, 2009;
284(22):
15084 - 15096.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Seppala, H Koistinen, R Koistinen, L Hautala, P C Chiu, and W S Yeung
Glycodelin in reproductive endocrinology and hormone-related cancer
Eur. J. Endocrinol.,
February 1, 2009;
160(2):
121 - 133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. D. Kopcow, F. Rosetti, Y. Leung, D. S. J. Allan, J. L. Kutok, and J. L. Strominger
T cell apoptosis at the maternal-fetal interface in early human pregnancy, involvement of galectin-1
PNAS,
November 25, 2008;
105(47):
18472 - 18477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Uchida, T. Maruyama, K. Ohta, M. Ono, T. Arase, M. Kagami, H. Oda, T. Kajitani, H. Asada, and Y. Yoshimura
Histone deacetylase inhibitor-induced glycodelin enhances the initial step of implantation
Hum. Reprod.,
October 1, 2007;
22(10):
2615 - 2622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Seppala, H. Koistinen, R. Koistinen, P.C.N. Chiu, and W.S.B. Yeung
Glycosylation related actions of glycodelin: gamete, cumulus cell, immune cell and clinical associations
Hum. Reprod. Update,
May 1, 2007;
13(3):
275 - 287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. C. N. Chiu, M.-K. Chung, R. Koistinen, H. Koistinen, M. Seppala, P.-C. Ho, E. H. Y. Ng, K.-F. Lee, and W. S. B. Yeung
Glycodelin-A interacts with fucosyltransferase on human sperm plasma membrane to inhibit spermatozoa-zona pellucida binding
J. Cell Sci.,
January 1, 2007;
120(1):
33 - 44.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ish-Shalom, A. Gargir, S. Andre, Z. Borovsky, Z. Ochanuna, H.-J. Gabius, M. L. Tykocinski, and J. Rachmilewitz
{alpha}2,6-Sialylation promotes binding of placental protein 14 via its Ca2+-dependent lectin activity: insights into differential effects on CD45RO and CD45RA T cells
Glycobiology,
March 1, 2006;
16(3):
173 - 183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Lapid and N. Sharon
Meet the multifunctional and sexy glycoforms of glycodelin
Glycobiology,
March 1, 2006;
16(3):
39R - 45R.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Dosiou and L. C. Giudice
Natural Killer Cells in Pregnancy and Recurrent Pregnancy Loss: Endocrine and Immunologic Perspectives
Endocr. Rev.,
February 1, 2005;
26(1):
44 - 62.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Mishan-Eisenberg, Z. Borovsky, M. C. Weber, R. Gazit, M. L. Tykocinski, and J. Rachmilewitz
Differential Regulation of Th1/Th2 Cytokine Responses by Placental Protein 14
J. Immunol.,
November 1, 2004;
173(9):
5524 - 5530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-H. Baek
Aberrant gene expression associated with recurrent pregnancy loss
Mol. Hum. Reprod.,
May 1, 2004;
10(5):
291 - 297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Koistinen, R. L. Easton, P. C.N. Chiu, S. Chalabi, M. Halttunen, A. Dell, H. R. Morris, W. S.B. Yeung, M. Seppala, and R. Koistinen
Differences in Glycosylation and Sperm-Egg Binding Inhibition of Pregnancy-Related Glycodelin
Biol Reprod,
November 1, 2003;
69(5):
1545 - 1551.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|